Keywords
Last Name

Thomas J. Moore, MD

TitleAssociate Provost
InstitutionBoston University Medical Campus
Address75 E. Newton St Evans Building
Boston MA 02118
Phone(617) 414-1325
ORCID ORCID Icon0000-0002-5289-2018
Other Positions
TitleProfessor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionEndocrinology, Diabetes & Nutrition

TitleGraduate Faculty (Primary Mentor of Grad Students)
InstitutionBoston University School of Medicine, Division of Graduate Medical Sciences

TitleActive Staff Privileges
InstitutionBoston Medical Center
DepartmentMedicine
DivisionEndocrinology, Diabetes & Nutrition

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Svetkey LP, Harris EL, Martin E, Vollmer WM, Meltesen GT, Ricchiuti V, Williams G, Appel LJ, Bray GA, Moore TJ, Winn MP, Conlin PR. Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. Am J Hypertens. 2011 Feb; 24(2):209-17. PMID: 21088669.
    View in: PubMed
  2. Rosenzweig JL, Taitel MS, Norman GK, Moore TJ, Turenne W, Tang P. Diabetes disease management in Medicare Advantage reduces hospitalizations and costs. Am J Manag Care. 2010 Jul; 16(7):e157-62. PMID: 20645661.
    View in: PubMed
  3. Sacks N, Cabral H, Kazis LE, Jarrett KM, Vetter D, Richmond R, Moore TJ. A web-based nutrition program reduces health care costs in employees with cardiac risk factors: before and after cost analysis. J Med Internet Res. 2009; 11(4):e43. PMID: 19861297.
    View in: PubMed
  4. Jacobs DR, Gross MD, Steffen L, Steffes MW, Yu X, Svetkey LP, Appel LJ, Vollmer WM, Bray GA, Moore T, Conlin PR, Sacks F. The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Kidney Dis. 2009 Apr; 53(4):638-46. PMID: 19167797.
    View in: PubMed
  5. Moore TJ, Alsabeeh N, Apovian CM, Murphy MC, Coffman GA, Cullum-Dugan D, Jenkins M, Cabral H. Weight, blood pressure, and dietary benefits after 12 months of a Web-based Nutrition Education Program (DASH for health): longitudinal observational study. J Med Internet Res. 2008; 10(4):e52. PMID: 19073541.
    View in: PubMed
  6. Moore TJ. Arterial hypertension and hypertensive encephalopathy. In Neurological Therapeutics Principles and Practice 2nd Edition. JH Noseworthy (editor-in-chief). Martin Dunitz Press. London. 2006.
  7. Vollmer WM, Appel LJ, Svetkey LP, Moore TJ, Vogt TM, Conlin PR, Proschan M, Harsha D. Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens. 2005 Jan; 19(1):77-82. PMID: 15361888.
    View in: PubMed
  8. Svetkey LP, Simons-Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, Moore TJ. Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control. J Clin Hypertens (Greenwich). 2004 Jul; 6(7):373-81. PMID: 15249792.
    View in: PubMed
  9. Moore TJ. The DASH Diet in the Control of Hypertension. Current Opinion in Endocrinology & Diabetes. 2004.
  10. Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ, Svetkey LP, Most-Windhauser MM, Cutler JA. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension. 2003 Oct; 42(4):459-67. PMID: 12953018.
    View in: PubMed
  11. Sacks FM, Appel LJ, Bray GA, Conlin PR, Moore TJ, Svetkey LP, Vollmer WM. Sodium and blood pressure: no data dredging, please! Am J Hypertens. 2003 Jul; 16(7):614-6. PMID: 12850399.
    View in: PubMed
  12. Conlin PR, Erlinger TP, Bohannon A, Miller ER, Appel LJ, Svetkey LP, Moore TJ. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Am J Hypertens. 2003 May; 16(5 Pt 1):337-42. PMID: 12745193.
    View in: PubMed
  13. Moore TJ. Arterial hypertension and hypertensive encephalopathy. In Neurological Therapeutics Principles and Practice. JH Noseworthy (editor-in-chief). Martin Dunitz Press. London. 2003.
  14. Erlinger TP, Conlin PR, Macko RF, Bohannon AD, Miller ER, Moore TJ, Svetkey LP, Appel LJ. The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis. J Hum Hypertens. 2002 Jun; 16(6):391-7. PMID: 12037693.
    View in: PubMed
  15. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001 Dec 18; 135(12):1019-28. PMID: 11747380.
    View in: PubMed
  16. Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM, Ard JD, Mortensen RM, Mitchell SR, Conlin PR, Kesari M. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens. 2001 Nov; 19(11):1949-56. PMID: 11677359.
    View in: PubMed
  17. Moore TJ, Conlin PR, Ard J, Svetkey LP. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001 Aug; 38(2):155-8. PMID: 11509468.
    View in: PubMed
  18. Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER, Lin PH, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, Bales CW, Proschan MA. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr. 2001 Jul; 74(1):80-9. PMID: 11451721.
    View in: PubMed
  19. Moore TJ, Svetkey LP, Karanja N, Lin PH, with Jenkins M. The DASH Diet for Hypertension. Simon & Schuster. New York. 2001.
  20. Conlin PR, Chow D, Miller ER, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens. 2000 Sep; 13(9):949-55. PMID: 10981543.
    View in: PubMed
  21. Conlin PR, Moore TJ, Swartz SL, Barr E, Gazdick L, Fletcher C, DeLucca P, Demopoulos L. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients. Hypertension. 2000 Sep; 36(3):461-5. PMID: 10988282.
    View in: PubMed
  22. Getchell WS, Svetkey LP, Appel LJ, Moore TJ, Bray GA, Obarzanek E. Summary of the Dietary Approaches to Stop Hypertension (DASH) Randomized Clinical Trial. Curr Treat Options Cardiovasc Med. 1999 Dec; 1(4):295-300. PMID: 11096495.
    View in: PubMed
  23. Moore TJ, Vollmer WM, Appel LJ, Sacks FM, Svetkey LP, Vogt TM, Conlin PR, Simons-Morton DG, Carter-Edwards L, Harsha DW. Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension. 1999 Sep; 34(3):472-7. PMID: 10489396.
    View in: PubMed
  24. Obarzanek E, Moore TJ. Using feeding studies to test the efficacy of dietary interventions: lessons from the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc. 1999 Aug; 99(8 Suppl):S9-11. PMID: 10450288.
    View in: PubMed
  25. Vogt TM, Appel LJ, Obarzanek E, Moore TJ, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Cutler JA, Windhauser MM, Lin PH, Karanja NM. Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc. 1999 Aug; 99(8 Suppl):S12-8. PMID: 10450289.
    View in: PubMed
  26. Harsha DW, Lin PH, Obarzanek E, Karanja NM, Moore TJ, Caballero B. Dietary Approaches to Stop Hypertension: a summary of study results. DASH Collaborative Research Group. J Am Diet Assoc. 1999 Aug; 99(8 Suppl):S35-9. PMID: 10450292.
    View in: PubMed
  27. Sacks FM, Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. Clin Cardiol. 1999 Jul; 22(7 Suppl):III6-10. PMID: 10410299.
    View in: PubMed
  28. Moore TJ, Appel LJ, Bray GA, Svetkey LP, Vollmer WM. More salt, please. The DASH Steering Committee. Science. 1998 Nov 6; 282(5391):1049-51. PMID: 9841451.
    View in: PubMed
  29. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ. Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension. 1998 Jan; 31(1):131-8. PMID: 9449404.
    View in: PubMed
  30. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997 Apr 17; 336(16):1117-24. PMID: 9099655.
    View in: PubMed
  31. Moore TJ, Rich G, McKnight JA, McCullough M, Hollenberg NK. Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril. Am J Hypertens. 1996 Jan; 9(1):54-60. PMID: 8834707.
    View in: PubMed
  32. Moore TJ, McKnight JA. Dietary factors and blood pressure regulation. Endocrinol Metab Clin North Am. 1995 Sep; 24(3):643-55. PMID: 8575414.
    View in: PubMed
  33. Hollenberg NK, Moore TJ. Age and the renal blood supply: renal vascular responses to angiotensin converting enzyme inhibition in healthy humans. J Am Geriatr Soc. 1994 Aug; 42(8):805-8. PMID: 8046189.
    View in: PubMed
  34. Chiou CY, Kifor I, Moore TJ, Williams GH. The effect of losartan on potassium-stimulated aldosterone secretion in vitro. Endocrinology. 1994 Jun; 134(6):2371-5. PMID: 8194463.
    View in: PubMed
  35. Fisher ND, Gleason RE, Moore TJ, Williams GH, Hollenberg NK. Regulation of aldosterone secretion in hypertensive blacks. Hypertension. 1994 Feb; 23(2):179-84. PMID: 8307626.
    View in: PubMed
  36. Williams GW, Moore TJ. Hormonal Aspects of Hypertension. In: DeGroot LJ et al., eds. Endocrinology. WB Saunders. 1994.
  37. Fisher ND, Allan D, Kifor I, Gaboury CL, Williams GH, Moore TJ, Hollenberg NK. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans. Hypertension. 1994 Jan; 23(1):44-51. PMID: 8282330.
    View in: PubMed
  38. McKnight JA, Moore TJ. The effects of dietary factors on blood pressure. Compr Ther. 1994; 20(9):511-7. PMID: 7805368.
    View in: PubMed
  39. Moore TJ, Brown EM. Hypercalcemia. In: Branch WT, ed. Office Practice of Medicine. 3rd ed. WB Saunders. Philadelphia. 1994.
  40. Conlin PR, Moore TJ, Williams GH, Hollenberg NK. Rapid modulation of renal and adrenal responsiveness to angiotensin II. Hypertension. 1993 Dec; 22(6):832-8. PMID: 7503952.
    View in: PubMed
  41. Seely EW, Moore TJ. The Renin-Angiotensin-Aldosterone System and Vasopressin. In: Maternal-Fetal Endocrinology, 2nd edit. Eds. D. Tulchinsky and B. Little. WB Saunders Co. Orlando. 1993.
  42. Williams GH, Dluhy RG, Lifton RP, Moore TJ, Gleason R, Williams R, Hunt SC, Hopkins PN, Hollenberg NK. Non-modulation as an intermediate phenotype in essential hypertension. Hypertension. 1992 Dec; 20(6):788-96. PMID: 1452294.
    View in: PubMed
  43. Graves SW, Moore TJ, Seely EW. Increased platelet angiotensin II receptor number in pregnancy-induced hypertension. Hypertension. 1992 Nov; 20(5):627-32. PMID: 1428114.
    View in: PubMed
  44. Moore TJ, Seely EW. Adrenal Insufficiency. In: May H, ed. Emergency Medicine, 2nd edit. Little, Brown and Co. Boston. 1992.
  45. Seely EW, Moore TJ. Adrenal Gland Physiology and Function. In: May H, ed. Emergency Medicine, 2nd edit. Little, Brown and Co. Boston. 1992.
  46. Rich GM, McCullough M, Olmedo A, Malarick C, Moore TJ. Blood pressure and renal blood flow responses to dietary calcium and sodium intake in humans. Am J Hypertens. 1991 Nov; 4(11):642S-645S. PMID: 1789949.
    View in: PubMed
  47. Kifor I, Moore TJ, Fallo F, Sperling E, Chiou CY, Menachery A, Williams GH. Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa. Endocrinology. 1991 Aug; 129(2):823-31. PMID: 1855477.
    View in: PubMed
  48. Goodfriend TL, Ball DL, Weinberger MH, Moore TJ, Weder AB, Egan BM. Salt loads raise plasma fatty acids and lower insulin. Hypertension. 1991 Jun; 17(6 Pt 2):958-64. PMID: 2045176.
    View in: PubMed
  49. Williams GH, Moore TJ, Hollenberg NK. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension. Endocrinol Metab Clin North Am. 1991 Jun; 20(2):423-47. PMID: 1879402.
    View in: PubMed
  50. Moore TJ, Malarick C, Olmedo A, Klein RC. Salt restriction lowers resting blood pressure but not 24-h ambulatory blood pressure. Am J Hypertens. 1991 May; 4(5 Pt 1):410-5. PMID: 2069774.
    View in: PubMed
  51. McCullough ML, Swain JF, Malarick C, Moore TJ. Feasibility of outpatient electrolyte balance studies. J Am Coll Nutr. 1991 Apr; 10(2):140-8. PMID: 2030256.
    View in: PubMed
  52. Cordero P, Fisher ND, Moore TJ, Gleason R, Williams GH, Hollenberg NK. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans. Hypertension. 1991 Apr; 17(4):510-6. PMID: 2013477.
    View in: PubMed
  53. Canessa M, Morgan K, Goldszer R, Moore TJ, Spalvins A. Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension. 1991 Mar; 17(3):340-8. PMID: 1847900.
    View in: PubMed
  54. Kifor I, Moore TJ, Fallo F, Sperling E, Menachery A, Chiou CY, Williams GH. The effect of sodium intake on angiotensin content of the rat adrenal gland. Endocrinology. 1991 Mar; 128(3):1277-84. PMID: 1999148.
    View in: PubMed
  55. Socorro L, Vallega G, Nunn A, Moore TJ, Canessa M. Vascular smooth muscle cells from the Milan hypertensive rat exhibit decreased functional angiotensin II receptors. Hypertension. 1990 Jun; 15(6 Pt 1):591-9. PMID: 2347621.
    View in: PubMed
  56. Underwood RH, Bradwin GR, Moore TJ, Williams GH. Semi-automated high-performance liquid chromatographic method for the simultaneous assay of plasma cortisol and 11-deoxycortisol in the metyrapone test. J Chromatogr. 1990 Mar 16; 526(1):180-5. PMID: 2341530.
    View in: PubMed
  57. Swartz SL, Moore TJ. Effect of angiotensin II on collagen-induced platelet activation in normotensive subjects. Thromb Haemost. 1990 Feb 19; 63(1):87-90. PMID: 2339363.
    View in: PubMed
  58. Moore TJ, Lazarus JM, Hakim RM. Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients. Kidney Int. 1989 Oct; 36(4):696-701. PMID: 2681934.
    View in: PubMed
  59. Seely EW, Moore TJ, LeBoff MS, Brown EM. A single dose of lithium carbonate acutely elevates intact parathyroid hormone levels in humans. Acta Endocrinol (Copenh). 1989 Aug; 121(2):174-6. PMID: 2505464.
    View in: PubMed
  60. Moore TJ. The role of dietary electrolytes in hypertension. J Am Coll Nutr. 1989; 8 Suppl:68S-80S. PMID: 2681329.
    View in: PubMed
  61. Seely EW, Moore TJ, Rogacz S, Gordon MS, Gleason RE, Hollenberg NK, Williams GH. Angiotensin-mediated renin suppression is altered in non-modulating hypertension. Hypertension. 1989 Jan; 13(1):31-7. PMID: 2642891.
    View in: PubMed
  62. Moore TJ. Insights into the mechanisms of action of ACE inhibitors. Osteop Ann. suppl. 1988; 15:10-14.
  63. Bradshaw B, Moore TJ. Abnormal regulation of adrenal angiotensin II receptors in spontaneously hypertensive rats. Hypertension. 1988 Jan; 11(1):49-54. PMID: 3338839.
    View in: PubMed
  64. Williams GH, Moore TJ, Hollenberg NK. Renal abnormalities in nonmodulating essential hypertension. Am J Kidney Dis. 1987 Jul; 10(1 Suppl 1):39-44. PMID: 3037888.
    View in: PubMed
  65. Moore TJ. The antihypertensive effect of angiotensin-converting enzyme inhibition: a multifaceted mechanism of action. J Am Osteopath Assoc. 1987 Feb; 87(2 Suppl):171-4. PMID: 3030977.
    View in: PubMed
  66. Moore TJ. Hypercalcemia. In: Branch WT, ed. Office Practice of Medicine 2nd ed. WB Saunders. Philadelphia. 1987.
  67. Adler GK, Moore TJ, Hollenberg NK, Williams GH. Changes in adrenal responsiveness and potassium balance with shifts in sodium intake. Endocr Res. 1987; 13(4):419-45. PMID: 3329091.
    View in: PubMed
  68. Williams GH, Moore TJ, Hollenberg NK. Renal abnormalities in non-modulating essential hypertension. Am J Kidney Dis Suppl. 1987; 1:39-44. .
  69. Isaacsohn JL, Lees AM, Lees RS, Strauss HW, Barlai-Kovach M, Moore TJ. Adrenal imaging with technetium-99m-labelled low density lipoproteins. Metabolism. 1986 Apr; 35(4):364-6. PMID: 3959906.
    View in: PubMed
  70. Moore TJ. Adrenal insufficiency. In: Hare J, ed. Signs and Symptoms in Endocrine and Metabolic Disorders. JB Lippincott Co. Philadelphia. 1986; 121-34.
  71. Goodman H, Sachs BP, Phillippe M, Moore T. Transient, recurrent nephrogenic diabetes insipidus. Am J Obstet Gynecol. 1984 Aug 15; 149(8):910-2. PMID: 6465262.
    View in: PubMed
  72. Moore TJ, Taylor T, Williams GH. Human platelet angiotensin II receptors: regulation by the circulating angiotensin level. J Clin Endocrinol Metab. 1984 May; 58(5):778-82. PMID: 6323514.
    View in: PubMed
  73. Koletsky RJ, Gordon MB, LeBoff MS, Moore TJ, Dluhy RG, Hollenberg NK, Williams GH. Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension. Clin Sci (Lond). 1984 Mar; 66(3):299-305. PMID: 6362960.
    View in: PubMed
  74. Taylor T, Moore TJ, Hollenberg NK, Williams GH. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension. Hypertension. 1984 Jan-Feb; 6(1):92-9. PMID: 6198274.
    View in: PubMed
  75. Moore TJ. Adrenal insufficiency. Annotated slide and audio cassette lecture. Medical Education Programs, Ltd. New York. 1984.
  76. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest. 1983 Dec; 72(6):2115-24. PMID: 6358261.
    View in: PubMed
  77. Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore TJ, Dluhy RG. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. J Clin Endocrinol Metab. 1983 Oct; 57(4):764-70. PMID: 6309884.
    View in: PubMed
  78. Gordon MB, Moore TJ, Dluhy RG, Williams GH. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes. Clin Endocrinol (Oxf). 1983 Oct; 19(4):415-25. PMID: 6354522.
    View in: PubMed
  79. Gordon MB, Moore TJ, Dluhy RG, Williams GH. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake. J Clin Endocrinol Metab. 1983 Feb; 56(2):340-5. PMID: 6822640.
    View in: PubMed
  80. Moore TJ, Williams GH. Acromegaly and hypertension. In: Robertson, J.I.S., ed. Handbook of hypertension - Clinical aspects of secondary hypertension. Elsevier Science Publishers. Amsterdam. 1983; 222-37..
  81. Moore TJ, Williams GH. Angiotensin II receptors on human platelets. Circ Res. 1982 Sep; 51(3):314-20. PMID: 6288286.
    View in: PubMed
  82. LeBoff Ms, Dluhy RG, Hollenberg NK, Moore TJ, Koletsky RJ, Williams GH. Abnormal renin short feedback loop in essential hypertension is reversible with converting enzyme inhibition. J Clin Invest. 1982 Aug; 70(2):335-41. PMID: 6284799.
    View in: PubMed
  83. Moore TJ. Hypercalcemia. In: Branch WT, ed. Office Practice of Medicine. WB Saunders. Philadelphia. 1982; 900-13.
  84. Dawson-Hughes BF, Moore TJ, Dluhy RG, Hollenberg NK, Williams GH. Plasma angiotensin II concentration regulates vascular but not adrenal responsiveness to restriction of sodium intake in normal man. Clin Sci (Lond). 1981 Nov; 61(5):527-34. PMID: 7026131.
    View in: PubMed
  85. Dawson-Hughes BF, Moore TJ, Dluhy RG, Podolsky S, Williams GH. Alterations in aldosterone biosynthesis in essential hypertensives. Circ Res. 1981 Sep; 49(3):627-32. PMID: 6266686.
    View in: PubMed
  86. Moore TJ, Crantz FR, Hollenberg NK, Koletsky RJ, Leboff MS, Swartz SL, Levine L, Podolsky S, Dluhy RG, Williams GH. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension. 1981 Mar-Apr; 3(2):168-73. PMID: 6260645.
    View in: PubMed
  87. Swartz SL, Moore TJ, Schoenbaum SC. Hypertension in pregnancy. In: Brenner BM, Stein JH, eds. Contemporary Issues in Nephrology - Hypertension. Churchill Livingstone. New York. 1981; 203-22.
  88. Swartz SL, Williams GH, Hollenberg NK, Crantz FR, Levine L, Moore TJ, Dluhy RG. Increase in prostaglandins during converting enzyme inhibition. Clin Sci (Lond). 1980 Dec; 59 Suppl 6:133s-135s. PMID: 6256109.
    View in: PubMed
  89. Swartz SL, Williams GH, Hollenberg NK, Crantz FR, Moore TJ, Levine L, Sasahara AA, Dluhy RG. Endocrine profile in the long-term phase of converting-enzyme inhibition. Clin Pharmacol Ther. 1980 Oct; 28(4):499-508. PMID: 6250761.
    View in: PubMed
  90. Crantz FR, Swartz SL, Hollenberg NK, Moore TJ, Dluhy RG, Williams GH. Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension. Hypertension. 1980 Sep-Oct; 2(5):604-9. PMID: 6158478.
    View in: PubMed
  91. Moore TJ, Thein-Wai W, Dluhy RG, Dawson-Hughes BF, Hollenberg NK, Williams GH. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly. J Clin Endocrinol Metab. 1980 Aug; 51(2):215-22. PMID: 6995474.
    View in: PubMed
  92. Swartz SL, Williams GH, Hollenberg NK, Levine L, Dluhy RG, Moore TJ. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest. 1980 Jun; 65(6):1257-64. PMID: 6997332.
    View in: PubMed
  93. Swartz SL, Williams GH, Hollenberg NK, Dluhy RG, Moore TJ. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction. J Clin Endocrinol Metab. 1980 Jun; 50(6):1071-4. PMID: 6989849.
    View in: PubMed
  94. Williams GH, Moore TJ. The renin-angiotensin-aldosterone axis. In: Tulchinsky D, Ryan KJ, eds. Maternal-Fetal Endocrinology. WB Saunders. Philadelphia. 1980; 84-96.
  95. Dluhy RG, Bavli SZ, Leung FK, Solomon HS, Moore TJ, Hollenberg NK, Williams GH. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. J Clin Invest. 1979 Nov; 64(5):1270-6. PMID: 500810.
    View in: PubMed
  96. Mersey JH, Williams GH, Emanuel R, Dluhy RG, Wong PY, Moore TJ. Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension. J Clin Endocrinol Metab. 1979 Apr; 48(4):642-7. PMID: 429510.
    View in: PubMed
  97. Williams GH, Hollenberg NK, Moore TJ, Swartz SL, Dluhy RG. The adrenal receptor for angiotensin II is altered in essential hypertension. J Clin Invest. 1979 Mar; 63(3):419-27. PMID: 219037.
    View in: PubMed
  98. Swartz SL, Williams GH, Hollenberg NK, Moore TJ, Dluhy RG. Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension. 1979 Mar-Apr; 1(2):106-11. PMID: 233366.
    View in: PubMed
  99. Moore TJ. Prolactinomas--Our raised consciousness. Arch Intern Med. 1979; 139:1223-4.
  100. Moore TJ, Williams GH. Adrenal causes of hypertension. Compr Ther. 1978 Dec; 4(12):46-52. PMID: 738012.
    View in: PubMed
  101. Dluhy RG, Moore TJ, Williams GH. Sella turcica enlargement and primary adrenal insufficiency. Ann Intern Med. 1978 Oct; 89(4):513-4. PMID: 697232.
    View in: PubMed
  102. Moore TJ, Braley LM, Williams GH. Stimulation of 18-hydroxy-11-deoxycorticosterone secretion by angiotensin II and potassium. Endocrinology. 1978 Jul; 103(1):152-5. PMID: 744066.
    View in: PubMed
  103. Williams GH, Hollenberg NK, Moore TJ, Dluhy RG, Bavli SZ, Solomon HS, Mersey JH. Failure of renin suppression by angiotensin II in hypertension. Circ Res. 1978 Jan; 42(1):46-52. PMID: 618602.
    View in: PubMed
  104. Moore TJ, Williams GH, Dluhy RG, Bavli SZ, Himathongkam T, Greenfield M. Altered renin-angiotensin-aldosterone relationships in normal renin essential hypertension. Circ Res. 1977 Aug; 41(2):167-71. PMID: 872289.
    View in: PubMed
  105. Williams GH, Dluhy RG, Moore TJ. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II. Mayo Clin Proc. 1977 May; 52(5):312-6. PMID: 870773.
    View in: PubMed
  106. Moore TJ, Dluhy RG, Williams GH, Cain JP. Nelson's syndrome: frequency, prognosis, and effect of prior pituitary irradiation. Ann Intern Med. 1976 Dec; 85(6):731-4. PMID: 999109.
    View in: PubMed
  107. Tuck ML, Williams GH, Dluhy RG, Greenfield M, Moore TJ. A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension. Circ Res. 1976 Nov; 39(5):711-7. PMID: 975459.
    View in: PubMed
  108. McCuskey RS, McClugage SG, Moore TJ, Miller ML. Response of the fetal mesenteric microvascular system to maternal hypoxia. Proc Soc Exp Biol Med. 1969 Nov; 132(2):636-9. PMID: 5355119.
    View in: PubMed
Thomas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department